{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:03:27Z","timestamp":1784293407242,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Istanbul University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40272-026-00755-4","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:44:40Z","timestamp":1781109880000},"page":"405-415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discontinuing Colchicine in Pediatric Familial\u00a0Mediterranean\u00a0Fever: Real-Life Experience from a Long-Term Follow-Up Cohort"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-1195","authenticated-orcid":false,"given":"Selen Duygu","family":"Ar\u0131k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7490-7076","authenticated-orcid":false,"given":"G\u00fcl\u015fah Kavrul","family":"Kayaalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8091-8417","authenticated-orcid":false,"given":"Ay\u015fenur Do\u011fru","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-9591","authenticated-orcid":false,"given":"Bengisu","family":"Menento\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5097-4479","authenticated-orcid":false,"given":"B\u00fc\u015fra Ba\u015fer","family":"Ta\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-0182","authenticated-orcid":false,"given":"Asl\u0131","family":"Dudakl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1386-4575","authenticated-orcid":false,"given":"Ay\u015fe","family":"Tanatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7216-0562","authenticated-orcid":false,"given":"\u00d6zlem","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-7387","authenticated-orcid":false,"given":"Nuray Aktay","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"8","key":"755_CR1","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","volume":"78","author":"M Gattorno","year":"2019","unstructured":"Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019;78(8):1025\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"755_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s11926-024-01147-8","volume":"26","author":"S Mirioglu","year":"2024","unstructured":"Mirioglu S, Uludag O, Hurdogan O, Kumru G, Berke I, Doumas SA, et al. AA amyloidosis: a contemporary view. Curr Rheumatol Rep. 2024;26(7):248\u201359.","journal-title":"Curr Rheumatol Rep"},{"key":"755_CR3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00043","volume":"8","author":"C de Torre-Minguela","year":"2017","unstructured":"de Torre-Minguela C, Mesa Del Castillo P, Pelegr\u00edn P. The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol. 2017;8:43.","journal-title":"Front Immunol"},{"key":"755_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01745","volume":"10","author":"O Schnappauf","year":"2019","unstructured":"Schnappauf O, Chae JJ, Kastner DL, Aksentijevich I. The pyrin inflammasome in health and disease. Front Immunol. 2019;10:1745.","journal-title":"Front Immunol"},{"issue":"18","key":"755_CR5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1056\/NEJM197410312911804","volume":"291","author":"CA Dinarello","year":"1974","unstructured":"Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial Mediterranean fever: a double-blind trial. N Engl J Med. 1974;291(18):934\u20137.","journal-title":"N Engl J Med"},{"issue":"16","key":"755_CR6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","volume":"314","author":"D Zemer","year":"1986","unstructured":"Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314(16):1001\u20135.","journal-title":"N Engl J Med"},{"issue":"1","key":"755_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1568010053622984","volume":"4","author":"C Cerquaglia","year":"2005","unstructured":"Cerquaglia C, Diaco M, Nucera G, La Regina M, Montalto M, Manna R. Pharmacological and clinical basis of treatment of familial Mediterranean fever (FMF) with colchicine or analogues: an update. Curr Drug Targets Inflamm Allergy. 2005;4(1):117\u201324.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"1","key":"755_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0049-0172(98)80028-0","volume":"28","author":"E Ben-Chetrit","year":"1998","unstructured":"Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum. 1998;28(1):48\u201359.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"755_CR9","first-page":"710","volume":"21","author":"E Ben-Chetrit","year":"1994","unstructured":"Ben-Chetrit E, Scherrmann JM, Zylber-Katz E, Levy M. Colchicine disposition in patients with familial Mediterranean fever with renal impairment. J Rheumatol. 1994;21(4):710\u20133.","journal-title":"J Rheumatol"},{"issue":"4","key":"755_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3109\/00365529409094847","volume":"29","author":"J Rudi","year":"1994","unstructured":"Rudi J, Raedsch R, Gerteis C, Schlenker T, Plachky J, Walter-Sack I, et al. Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment. Scand J Gastroenterol. 1994;29(4):346\u201351.","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"755_CR11","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.30389","volume":"63","author":"RA Terkeltaub","year":"2011","unstructured":"Terkeltaub RA, Furst DE, Digiacinto JL, Kook KA, Davis MW. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors. Arthritis Rheum. 2011;63(8):2226\u201337.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"755_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10067-016-3421-8","volume":"36","author":"HE S\u00f6nmez","year":"2017","unstructured":"S\u00f6nmez HE, Batu ED, Bilginer Y, \u00d6zen S. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants. Clin Rheumatol. 2017;36(2):421\u20135.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"755_CR13","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/rheumatology\/kez156","volume":"58","author":"A Tanatar","year":"2019","unstructured":"Tanatar A, Karada\u011f \u015eG, S\u00f6nmez HE, \u00c7akan M, Aktay Ayaz N. Short-term follow-up results of children with familial Mediterranean Fever after cessation of colchicine: is it possible to quit? Rheumatology (Oxf). 2019;58(10):1818\u201321.","journal-title":"Rheumatology (Oxf)"},{"key":"755_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-3","volume":"9","author":"I Ben-Zvi","year":"2014","unstructured":"Ben-Zvi I, Krichely-Vachdi T, Feld O, Lidar M, Kivity S, Livneh A. Colchicine-free remission in familial Mediterranean Fever: featuring a unique subset of the disease-a case control study. Orphanet J Rare Dis. 2014;9:3.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"755_CR15","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3899\/jrheum.201158","volume":"48","author":"YB Aviel","year":"2021","unstructured":"Aviel YB, Rawan S, Fahoum S, Wexler I, Berkun Y. Discontinuation of colchicine therapy in children with familial Mediterranean Fever. J Rheumatol. 2021;48(11):1732\u20135.","journal-title":"J Rheumatol"},{"issue":"1","key":"755_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00780-w","volume":"21","author":"K Cohen","year":"2023","unstructured":"Cohen K, Spielman S, Semo-Oz R, Bitansky G, Gerstein M, Yacobi Y, et al. Colchicine treatment can be discontinued in a selected group of pediatric FMF patients. Pediatr Rheumatol Online J. 2023;21(1):2.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"11","key":"755_CR17","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1093\/rheumatology\/keaf340","volume":"64","author":"V Cam","year":"2025","unstructured":"Cam V, Unal D, Sag E, Bayindir Y, Aliyev E, Emreol HE, et al. Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study. Rheumatology (Oxf). 2025;64(11):5726\u201332.","journal-title":"Rheumatology (Oxf)"},{"issue":"2","key":"755_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","volume":"43","author":"E Sohar","year":"1967","unstructured":"Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean Fever: a survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227\u201353.","journal-title":"Am J Med"},{"issue":"2","key":"755_CR19","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s10067-025-07874-2","volume":"45","author":"B Aktas","year":"2026","unstructured":"Aktas B, Parlar K, Senturk B, Saglam A, Dundar A, Uc C, et al. Colchicine discontinuation in familial Mediterranean Fever: short-term outcomes by pre-discontinuation attack frequency. Clin Rheumatol. 2026;45(2):1257\u201365.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"755_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/RHU.0000000000001953","volume":"29","author":"H Kisaoglu","year":"2023","unstructured":"Kisaoglu H, Baba O, Kalyoncu M. Genotype-phenotype associations of children with familial Mediterranean Fever in a cohort consisting of M694V mutation and implications for colchicine-resistant disease. J Clin Rheumatol. 2023;29(4):207\u201313.","journal-title":"J Clin Rheumatol"},{"issue":"12","key":"755_CR21","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1136\/annrheumdis-2011-200977","volume":"71","author":"S Federici","year":"2012","unstructured":"Federici S, Calcagno G, Finetti M, Gallizzi R, Meini A, Vitale A, et al. Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. Ann Rheum Dis. 2012;71(12):1961\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"755_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/annrheumdis-2014-206844","volume":"74","author":"G Giancane","year":"2015","unstructured":"Giancane G, Ter Haar NM, Wulffraat N, Vastert SJ, Barron K, Hentgen V, et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis. 2015;74(4):635\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"755_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00296-020-04592-7","volume":"41","author":"NA Ayaz","year":"2021","unstructured":"Ayaz NA, Tanatar A, Karada\u011f \u015eG, \u00c7akan M, Keskindemirci G, S\u00f6nmez HE. Comorbidities and phenotype-genotype correlation in children with Familial Mediterranean Fever. Rheumatol Int. 2021;41(1):113\u201320.","journal-title":"Rheumatol Int"},{"issue":"5","key":"755_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/RHU.0000000000001261","volume":"27","author":"A Tanatar","year":"2021","unstructured":"Tanatar A, Karada\u011f \u015eG, S\u00f6nmez HE, \u00c7akan M, Ayaz NA. Comparison of pediatric Familial Mediterranean Fever patients carrying only E148Q variant with the ones carrying homozygous pathogenic mutations. J Clin Rheumatol. 2021;27(5):182\u20136.","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"755_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1098-1004(200004)15:4<385::AID-HUMU22>3.0.CO;2-A","volume":"15","author":"EI Ben-ChetritLerer","year":"2000","unstructured":"Ben-ChetritLerer EI, Malamud E, Domingo C, Abeliovich D. The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? Hum Mutat. 2000;15(4):385\u20136.","journal-title":"Hum Mutat"},{"issue":"4","key":"755_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/humu.9182","volume":"22","author":"D Tchernitchko","year":"2003","unstructured":"Tchernitchko D, Legendre M, Cazeneuve C, Delahaye A, Niel F, Amselem S. The E148Q MEFV allele is not implicated in the development of Familial Mediterranean Fever. Hum Mutat. 2003;22(4):339\u201340.","journal-title":"Hum Mutat"},{"issue":"1","key":"755_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semarthrit.2019.08.004","volume":"50","author":"E Sag","year":"2020","unstructured":"Sag E, Demirel D, Demir S, Atalay E, Akca U, Bilginer Y, et al. Performance of the new \u2018Eurofever\/PRINTO classification criteria\u2019 in FMF patients. Semin Arthritis Rheum. 2020;50(1):172\u20135.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"755_CR28","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00431-021-04370-y","volume":"181","author":"EN Akyol Onder","year":"2022","unstructured":"Akyol Onder EN, Ozcan KE, Sahin FI, Gulleroglu KS, Baskin E. Comparison of diagnostic criteria for children with Familial Mediterranean Fever. Eur J Pediatr. 2022;181(4):1661\u20137.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"755_CR29","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/annrheumdis-2015-208671","volume":"75","author":"E Demirkaya","year":"2016","unstructured":"Demirkaya E, Acikel C, Hashkes P, Gattorno M, Gul A, Ozdogan H, et al. Development and initial validation of international severity scoring system for Familial Mediterranean Fever (ISSF). Ann Rheum Dis. 2016;75(6):1051\u20136.","journal-title":"Ann Rheum Dis"},{"key":"755_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.805919","volume":"9","author":"K \u00d6zt\u00fcrk","year":"2021","unstructured":"\u00d6zt\u00fcrk K, Co\u015fkuner T, Baglan E, S\u00f6nmez HE, Yener GO, \u00c7akmak F, et al. Real-life data from the largest pediatric familial Mediterranean fever cohort. Front Pediatr. 2021;9:805919.","journal-title":"Front Pediatr"},{"issue":"4","key":"755_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644\u201351.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"755_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004677","volume":"10","author":"I Elhani","year":"2024","unstructured":"Elhani I, Backes S, Kallinich T, Amaryan G, Belot A, Berendes R, et al. Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever. RMD Open. 2024;10(4):e004677.","journal-title":"RMD Open"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00755-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:11:08Z","timestamp":1784290268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-026-00755-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1007\/s40272-026-00755-4","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Selen Duygu Ar\u0131k, G\u00fcl\u015fah Kavrul Kayaalp, Ay\u015fenur Do\u011fru K\u0131l\u0131n\u00e7, Bengisu Menento\u011flu, B\u00fc\u015fra Ba\u015fer Ta\u015fk\u0131n, Asl\u0131 Dudakl\u0131, Ay\u015fe Tanatar, \u00d6zlem Akg\u00fcn, and Nuray Aktay Ayaz have no conflicts of interest that are directly relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflicts of Interest\/Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of Istanbul University, Istanbul Medicinal Faculty (date: 05.02.2024; No: 2405744). The study was carried out and complied with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients and\/or their parents or legal guardians prior to inclusion in this study.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by SDA, \u00d6A, and NAA. The first draft of the manuscript was written by SDA, and all authors commented on earlier versions. All authors read and approved the final manuscript.","order":7,"name":"Ethics","label":"Authors\u2019 Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}